Cryolife purchased this from Genesee for $2.3 million in cash in April this year.
and they are publically stating they sold 1million + dollars just in US of Photofix in 1st yea
they have a fat new publication 300+ patients from world renowned centre with strong clinical evidence + a global experience sales & distribution team they can probably afford to take a cut on profitability to get this in the market as not a 1shot pony.- and increased significantly SHV. Shame management at this company dont take a lesson and have not raised their game and created some world-class alliances to compete - this could hurt them badly if they dont pay attention
Photo-oxidized bovine pericardium in congenital cardiac surgery: single-centre experience, page-18
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.55 |
Change
-0.130(1.11%) |
Mkt cap ! $244.1M | |||
| Open | High | Low | Value | Volume |
| $11.71 | $11.89 | $11.41 | $703.3K | 60.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $11.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.83 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |